GSK-3β inhibition attenuates CLP-induced liver injury by reducing inflammation and hepatic cell apoptosis.
Zhang, Hui
GSK-3β inhibition attenuates CLP-induced liver injury by reducing inflammation and hepatic cell apoptosis. [electronic resource] - Mediators of inflammation 2014 - 629507 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1466-1861
10.1155/2014/629507 doi
Animals
Apoptosis
Cell Line
Cytokines--metabolism
Enzyme-Linked Immunosorbent Assay
Glycogen Synthase Kinase 3--metabolism
Glycogen Synthase Kinase 3 beta
Immunohistochemistry
Indoles--chemistry
Inflammation--metabolism
Interleukin-6--metabolism
Leukocytes--cytology
Liver--injuries
Male
Maleimides--chemistry
Mice
Mice, Inbred C57BL
NF-kappa B--metabolism
Peroxidase--metabolism
Signal Transduction
GSK-3β inhibition attenuates CLP-induced liver injury by reducing inflammation and hepatic cell apoptosis. [electronic resource] - Mediators of inflammation 2014 - 629507 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1466-1861
10.1155/2014/629507 doi
Animals
Apoptosis
Cell Line
Cytokines--metabolism
Enzyme-Linked Immunosorbent Assay
Glycogen Synthase Kinase 3--metabolism
Glycogen Synthase Kinase 3 beta
Immunohistochemistry
Indoles--chemistry
Inflammation--metabolism
Interleukin-6--metabolism
Leukocytes--cytology
Liver--injuries
Male
Maleimides--chemistry
Mice
Mice, Inbred C57BL
NF-kappa B--metabolism
Peroxidase--metabolism
Signal Transduction